Mount Cook Biosciences

Mount Cook Biosciences is a private biotechnology company focused on developing next-generation therapies for inflammatory and autoimmune diseases. The company employs a precision medicine approach, leveraging deep biological insights to target specific pathways in immune-mediated conditions. Backed by The Column Group, Mount Cook aims to translate complex immunology into transformative treatments for patients with high unmet needs. The firm is currently in the pre-clinical stage, building a proprietary pipeline of therapeutics. Headquartered in San Francisco, the company is led by experienced industry veterans with a track record of successful drug discovery.